DG

Dnyaneshwar Gambhir Patil

Active Director Director DIN 07530938
DIN 07530938 First appointment Jun 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Dnyaneshwar Gambhir Patil

Data last updated:

Dnyaneshwar Gambhir Patil is a Director at Relevium Pharma Private Limited (since 2016). The company operates in Trading. Relevium Pharma Private Limited reported revenue of ₹81.3 Lakh (FY 2025).

DIN 07530938
Primary Designation Director
Industry Trading
First Appointment 23 Jun 2016
Oldest Company Age 10 yrs
Largest company Relevium Pharma Private Limited · ₹81.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Relevium Pharma Private Limited U74999MH2016PTC282810
Director23 Jun 20162016₹81.3 Lakh (FY 2025)Active

Board colleagues of Dnyaneshwar Gambhir Patil

NameDINCompanyDesignation
Shankar Bhagwanrao Jadhav08941043Relevium Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Relevium Pharma Private Limited
Premium access

Shareholding and investment profile for Dnyaneshwar Gambhir Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dnyaneshwar Gambhir Patil

Dnyaneshwar Gambhir Patil currently holds 1 directorship: Relevium Pharma Private Limited (Director, since 23 Jun 2016, revenue ₹81.3 Lakh (FY 2025)).

Dnyaneshwar Gambhir Patil was first appointed on 23 Jun 2016 as Director at Relevium Pharma Private Limited.

The current boards of Dnyaneshwar Gambhir Patil's companies include Shankar Bhagwanrao Jadhav (Relevium Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available